Uterine Cancer Diagnosis After Hysterectomy May Have Been Caused by Fibroid Morcellation
Many women diagnosed in recent years with leiomyosarcoma, endometrial stromal sarcoma or other uterine cancer following a hysterectomy or myomectomy remain unaware that the use of power morcellators during a prior fibroid surgery may be to blame for the spread of their cancer.
Power morcellators are medical devices that have been used in more than 50,000 laparoscopic and robotic surgical procedures each year, allowing the doctors to cut up and remove the uterus or uterine fibroids through an incision in the abdomen. However, the medical community has recently come to recognize that these surgical tools pose an unreasonable risk of spreading aggressive uterine cancers throughout the body.
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential uterine cancer lawsuits for women throughout the United States who have been diagnosed with the dissemination of leiomyosarcoma, endometrial stromal sarcoma or other cancerous tissue following a hysterectomy or myomectomy where morcellation may have been performed.
Morcellators May Spread Uterine Cancers
Over the past decade, manufacturers have promoted power morcellators as a superior way of treating symptomatic uterine fibroids through a minimally invasive surgery, providing shorter recovery times, less scarring and reduced risk of infection or other complications.
Although these devices were promoted as safe, it has now become clear that they pose an unreasonable risk for many of women who undergo a laparoscopic hysterectomy or myomectomy.
Recent estimates suggest that 1 out of every 350 women who undergo uterine fibroid morcellation have unsuspected uterine cancer, which doctors have no way of detecting prior to the procedure. Use of a morcellator may cause this cancerous tissue that is contained within the uterus to be spread throughout the woman’s body, causing rapid uterine cancer dissemination to a stage that is extremely aggressive and hard to treat.
Manufacturers knew or should have known about the uterine cancer risks with fibroid morcellation, yet it appears that they placed their desire for profits before the safety of women by withholding information from consumers and the medical community. The first warnings were not provided until April 2014, when the FDA urged doctors to avoid use of the devices during laparoscopic hysterectomy or myomectomy procedures.
Last month, the FDA announced that “black box” warnings will be placed on power morcellators (PDF) and steps are now being taken to ensure that any women considering uterine fibroid surgery with morcellation are aware of the risk that the devices may spread cancer. However, most women who previously underwent a procedure involving use of a morcellator remain unaware that these dangerous surgical tools may have caused the progression of their uterine cancer.
Hysterectomy Morcellation Uterine Cancer Lawyers
Potential claims are now being reviewed by the uterine cancer lawyers at Saiontz & Kirk, P.A. for women throughout the United States who have been diagnosed with the dissemination of leiomyosarcoma, endometrial stromal sarcoma or other health problems that may have been caused by use of a power morcellator during:
All cases are being pursued under a contingency fee agreement, which means that there are no out-of-pocket expenses to hire our law firm and we receive no attorney fees or expenses unless a recovery is obtained. To review a potential claim for yourself, a friend or family member, request a free consultation and claim evaluation.